Barclays initiates Edwards Lifesciences at Overweight, $110 target
Barclays initiated Edwards Lifesciences with an Overweight rating and a $110.00 per-share price target.
Story updates
12:57:44 PM UTC
SquawkNews
Edwards Lifesciences Price Target Announced at $110.00/Share by Barclays